DelveInsight’s “Athlete’s Foot Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Athlete’s Foot pipeline landscapes. It comprises Athlete’s Foot pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Athlete’s Foot therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Athlete’s Foot pipeline products.
Some of the key takeaways of the Athlete’s Foot Pipeline Report
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as Blueberry Therapeutics Ltd, DermBiont, etc., are developing therapies to treat athletes’ feet.
Emerging therapies such as BB2603, DBI-001, are expected to have a significant impact on the Athlete’s Foot market in the coming years.
Douglas Pharmaceuticals America in collaboration with ACM Global Laboratories and Novum Pharmaceutical Research Services initiated a phase III randomized, double-blind,vehicle-controlled, parallel-design,multiple-site study to evaluate the therapeutic equivalence of ketoconazole cream 2% to Ketoconazole Cream 2% in the treatment of Tinea Pedis.
Get an overview of pipeline landscape @ Athlete’s Foot Clinical Trials Analysis
An athlete’s foot is a fungal infection that affects the upper layer of the skin of the foot, especially when it is warm, moist, and irritated. It is also known as tinea Pedi and ringworm of the foot. The fungus that causes an athlete’s foot is called Trichophyton and is commonly found on floors and in clothing.
Athlete’s Foot Emerging Drugs
BB2603 by Blueberry Therapeutics Ltd
DBI-001 by DermBiont
And others.
Scope of Athlete’s Foot Pipeline Drug Insight
Coverage: Global
Major Players: Blueberry Therapeutics Ltd, DermBiont, and others.
Pipeline Therapies: BB2603, DBI-001, and others.
Table of Contents
1
Athlete’s Foot Report Introduction
2
Athlete’s Foot Executive Summary
3
Athlete’s Foot Overview
4
Athlete’s Foot- Analytical Perspective In-depth Commercial Assessment
5
Athlete’s Foot Pipeline Therapeutics
6
Athlete’s Foot Late Stage Products (Phase II/III)
7
Athlete’s Foot Mid Stage Products (Phase II)
8
Athlete’s Foot Early Stage Products (Phase I)
9
Athlete’s Foot Preclinical Stage Products
10
Athlete’s Foot Therapeutics Assessment
11
Athlete’s Foot Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Athlete’s Foot Key Companies
14
Athlete’s Foot Key Products
15
Athlete’s Foot Unmet Needs
16
Athlete’s Foot Market Drivers and Barriers
17
Athlete’s Foot Future Perspectives and Conclusion
18
Athlete’s Foot Analyst Views
19
Appendix
20
About DelveInsight
Related Reports:
Athlete’s Foot Market
DelveInsight’s ‘Athlete’s Foot – Market Insights, Epidemiology, and Market Forecast-2030’ report deliver an in-depth understanding of the Athlete’s Foot, historical and forecasted epidemiology as well as the Athlete’s Foot market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Athlete’s Foot Epidemiology
DelveInsight’s ‘Athlete’s Foot- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Athlete’s Foot epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/